All Clinical Trials

A listing of 23101 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Trials

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Offer

Lose Weight with GLP-1 Medications

Recruiting

Policy Lab has partnered with CareGLP to offer trusted access to GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.

As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma

NCT06356571

Recruiting

The primary purpose of this study is to assess the efficacy (overall response rate) of subcutaneous (SC) via on body delivery system (SC-OBDS) isatuximab in combination with weekly carfilzomib and dexamethasone (Kd) in adult participants with RRMM having received 1 to 3 prior lines of therapy.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

05/16/2025

Locations: Smilow Cancer Center at Yale-New Haven- Site Number : 8400020, New Haven, Connecticut +9 locations

Conditions: Plasma Cell Myeloma Refractory

Learn More ›

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)

NCT06611553

Recruiting

This clinical trial evaluates the use of self-collected vaginal samples for human papillomavirus (HPV) testing in patients referred for a colposcopy and/or cervical excisional procedures to improve cervical cancer prevention. HPV is a common virus which usually causes infections that last only a few months, but sometimes can last longer. It is known to cause a variety of cancers including cancer of the cervix. Even though there are ways to detect cervical cancer early, many individuals do not undergo screening that involves pelvic exams. Over half of all new cervical cancer cases are among those who have either never been screened or who are not screened enough. Without appropriate screening and care, preventable pre-cancers may turn into cancer. A new way to detect cervical cancer is to have individuals collect their own vaginal sample for HPV testing to know their risk for cervical cancer. This may give individuals more flexibility and comfort having the ability to collect samples themselves, compared to a doctor performing a speculum examination and collecting the samples in a clinic. This study compares clinical accuracy of HPV testing on self-collected vaginal samples versus cervical samples collected by clinician. The Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial is part of the National Cancer Institute (NCI)'s Cervical Cancer 'Last Mile' Initiative, a public private partnership that seeks to increase access to cervical cancer screening. The SHIP Trial focuses on developing clinical evidence to inform the US Food and Drug Administration (FDA)'s regulatory reviews of self-collection approaches as alternative sample collection approaches for cervical cancer screening. Several industry partner-specific self-collection device and assay combinations will be non-competitively and independently evaluated with a similar study design framework to inform pre-approval and/or post-approval regulatory requirements. Read Less

Gender:

FEMALE

Ages:

25 years and above

Trial Updated:

05/16/2025

Locations: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama +24 locations

University of Alabama at Birmingham Cancer Center, Birmingham, Alabama

UCSF Medical Center-Parnassus, San Francisco, California

Yale University, New Haven, Connecticut

University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida

Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia

UofL Health Medical Center Northeast, Louisville, Kentucky

Louisiana State University Health Science Center, New Orleans, Louisiana

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland

University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan

Minneapolis VA Medical Center, Minneapolis, Minnesota

University of Mississippi Medical Center, Jackson, Mississippi

University of New Mexico Cancer Center, Albuquerque, New Mexico

Montefiore Medical Center-Einstein Campus, Bronx, New York

NYP/Weill Cornell Medical Center, New York, New York

UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina

University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio

Cleveland Clinic Foundation, Cleveland, Ohio

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania

UPMC-Magee Womens Hospital, Pittsburgh, Pennsylvania

M D Anderson Cancer Center, Houston, Texas

Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah

Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia

University of Washington Medical Center - Northwest, Seattle, Washington

University of Puerto Rico, San Juan, Not set

Conditions: Cervical Carcinoma, Human Papillomavirus Infection

Learn More ›

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

NCT06858579

Recruiting

The purpose of this Phase 3 study is to demonstrate the efficacy of DNTH103 as compared to placebo in participants with chronic inflammatory demyelinating polyneuropathy (CIDP).

Gender:

ALL

Ages:

Between 18 years and 75 years

Trial Updated:

05/16/2025

Locations: Clinical Study Site, Maitland, Florida +9 locations

Conditions: Chronic Inflammatory Demyelinating Polyneuropathy

Learn More ›

Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer

NCT00033137

Recruiting

This study will investigate the genetic cause of Birt Hogg-Dube (BHD) syndrome and the relationship of this disorder to kidney cancer. BHD is a rare inherited condition characterized by papules, or bumps benign tumors involving hair follicles on the head and neck. People with BHD are at increased risk of developing kidney cancer. Scientists have identified the chromosome (strand of genetic material in the cell nucleus) that contains the BHD gene and the region of the gene on the chromosome. This study will try to learn more about: * The characteristics and type of kidney tumors associated with BHD * The risk of kidney cancer in people with BHD * Whether more than one gene causes BHD * The genetic mutations (changes) responsible for BHD Patients with known or suspected Birt Hogg-Dube syndrome, and their family members, may be eligible for this study. Candidates will be screened with a family history and review of medical records, including pathology reports for tumors, and films of computed tomography (CT) and magnetic resonance imaging (MRI) scans. Participants may undergo various tests and procedures, including the following: * Physical examination * Review of personal and family history with a cancer doctor, cancer nurses, kidney surgeon, and genetic counselor * Chest and other x-rays * Ultrasound (imaging study using sound waves) * MRI (imaging study using radiowaves and a magnetic field) * CT scans of the chest and abdomen (imaging studies using radiation) * Blood tests for blood chemistries and genetic testing * Skin evaluation, including a skin biopsy (surgical removal of a small skin tissue sample for microscopic evaluation) * Cheek swab or mouthwash to collect cells for genetic analysis * Lung function studies * Medical photography of skin lesions These tests will be done on an outpatient basis in either one day or over 3 to 4 days. When the studies are complete, participants will receive counseling about the findings and recommendations. Patients with kidney lesions may be asked to return periodically, such as every 3 to 36 months, based on their individual condition, to document the rate of progression of the lesions. ... Read Less

Gender:

ALL

Ages:

2 years and above

Trial Updated:

05/16/2025

Locations: National Institutes of Health Clinical Center, Bethesda, Maryland

Conditions: Kidney Neoplasms, Kidney Cancer, Pneumothorax, FLCN Protein, Human

Learn More ›

A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP

NCT04850118

Recruiting

This study will evaluate and compare the safety, efficacy, and tolerability of 2 doses of a recombinant adeno-associated virus vector (AGTC-501/laruparetigene zovaparvovec )) to an untreated control group in male participants with X-linked retinitis pigmentosa caused by RPGR mutations.

Gender:

MALE

Ages:

Between 12 years and 50 years

Trial Updated:

05/16/2025

Locations: Retina Macula Institute of Arizona, Scottsdale, Arizona +23 locations

Retina Macula Institute of Arizona, Scottsdale, Arizona

Children's Hospital Los Angeles, Los Angeles, California

University of Florida Health Jacksonville, Department of Ophthalmology, Jacksonville, Florida

Bascom Palmer Eye Institute- University of Miami, Miami, Florida

Midwest Eye Institute (Retina Partners Midwest), Carmel, Indiana

Wilmer Eye Institute at Johns Hopkins, Baltimore, Maryland

Ophthalmic Consultants of Boston, Boston, Massachusetts

Mayo Clinic, Rochester, Minnesota

Duke Eye Center, Durham, North Carolina

Cincinnati Eye Institute, Cincinnati, Ohio

Cole Eye Institute - Cleveland Clinic, Cleveland, Ohio

Casey Eye Institute, OHSU, Portland, Oregon

The Center for Advanced Retinal & Ocular Therapeutics University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania

Mid Atlantic Retina, Philadelphia, Pennsylvania

University of Pittsburgh, Pittsburgh, Pennsylvania

Retina Consultants of Texas, Bellaire, Texas

Retina Foundation of the Southwest, Dallas, Texas

Baylor Eye Institute, Houston, Texas

Retina Consultants of San Antonio Texas, San Antonio, Texas

Sydney Eye Hospital, Sydney, New South Wales

Royal Victorian Eye & Ear Hospital, East Melbourne, Victoria

Moorfields Eye Hospital, London, Not set

The Retina Clinic London, Institute of Ophthalmology, University College London, London, Not set

Oxford Eye Hospital, Oxford, Not set

Conditions: X-Linked Retinitis Pigmentosa

Learn More ›

Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer

NCT05502237

Recruiting

The primary objective of this study is to compare the effect of zimberelimab (ZIM) and domvanalimab (DOM) in combination with chemotherapy relative to pembrolizumab (PEMBRO) in combination with chemotherapy on overall survival (OS) in patients with untreated metastatic non-small cell lung cancer with no actionable genomic alteration.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

05/16/2025

Locations: Palo Verde Hematology Oncology Ltd, Glendale, Arizona +224 locations

Palo Verde Hematology Oncology Ltd, Glendale, Arizona

California Cancer Associates for Research and Excellence, San Marcos, California

Texas Oncology, Santa Barbara, California

Innovative Clinical Research Institute, Whittier, California

Eastern CT Hematology and Oncology Associates, Norwich, Connecticut

Lake City Cancer Care, Lake City, Florida

Florida Cancer Specialists, Sarasota, Florida

Moffitt Cancer Center, Tampa, Florida

Peachtree Hematology Oncology Consultants, Atlanta, Georgia

Illinois Cancer Care, Peoria, Illinois

Messino Cancer Centers, Asheville, North Carolina

Oncology Hematology Care, Inc., Cincinnati, Ohio

Hematology & Oncology Associates, Eugene, Oregon

AHN Allegheny General Hospital, Pittsburgh, Pennsylvania

Arlington Cancer Center, Arlington, Texas

Texas Oncology - Austin, Austin, Texas

Texas Oncology, Dallas, Texas

Texas Oncology- Denison, Sherman, Texas

US Oncology Investigational Products Center (IPC), Arlington, Virginia

Oncology and Hematology Associates of Southwest Virginia, Inc, Blacksburg, Virginia

Northwest Cancer Specialists, PC, Vancouver, Washington

Investigaciones CORI S.R.L., Capital, Not set

Centro Médico Privado Centro de Especialidades Médicas Ambulatorias e Investigación Clínica, Cardoba, Not set

Centro Medico Barrio Parque, Ciudad Autanoma Buenos Aires, Not set

Sanatorio Allende, Cordoba, Not set

Sanatorio Britanico de Rosario, Rosario, Not set

Sanatorio Parque de Rosario, Rosario, Not set

Hospital Provincial del Centenario, Rosario, Not set

Instituto Medico de la Fundacion Estudios Clinicos, Rosario, Not set

CAIPO - Centro para la Atención Integral del Paciente Oncológico, San Miguel de Tucumán, Not set

Clínica Viedma, Viedma, Not set

Klinikum Klagenfurt am Woerthersee, Klagenfurt Am Woerthersee, Not set

Ordensklinikum Linz GmbH, Elisabethinen, Linz, Not set

Klinikum Wels-Grieskirchen, Wels, Not set

Krankenhaus Nord - Klinik Floridsdorf, Wien, Not set

Algemeen Ziekenhuis Sint-Lucas, Aalst, Not set

Grand Hopital de Charleroi asbl (GHdC), Charleroi, Not set

AZ Sint-Maarten, Mechelen, Not set

CHU UCL Namur / Site Sainte Elisabeth, Namur, Not set

Cenantron Centro Avançado de Tratamento Oncologico Ltda, Belo Horizonte, Not set

Hospital Evangelico de Cachoeiro de Itapemirim, Cachoeiro De Itapemirim, Not set

Fundacao Universidade De Caxias Do Sul - FUCS/RS, Caxias Do Sul, Not set

Instituto do Câncer do Ceará - ICC, Fortaleza, Not set

Oncosite - Centro de Pesquisa Clinica em Oncologia LTDA, Ijui, Not set

Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Not set

Hospital de Clínicas de Porto Alegre, Porto Alegre, Not set

Hospital São Lucas da PUCRS, Porto Alegre, Not set

Hospital Ana Nery Santa Cruz do Sul, Santa Cruz Do Sul, Not set

Centro Des Pesquisas Clinicas da Fundacao Doutor Amaral Carvalho, Sao Paolo, Not set

Instituto Brasiliero de Controle do Cancer IBCC, Sao Paulo, Not set

Centre Integre de sante et de services sociaux de la Monteregie Centre, Greenfield Park, Not set

Moncton Hospital, Moncton, Not set

CISSS des Laurentides, Quebec, Not set

Centre de santé et services sociaux de Rimouski-Neigette, Rimouski, Not set

BC Cancer - Victoria, Victoria, Not set

Clinica Alemana de Santiago, Las Condes, Not set

Orlandioncologia, Providencia, Not set

Oncovida- Santiago, Providencia, Not set

Clinica Puerto Montt, Puerto Montt, Not set

Biocinetic, Santiago, Not set

James Lind Centro de Investigacion del Cancer, Temuco, Not set

Oncocentro APYS, Vina del Mar, Not set

West China Hospital Sichuan University, Chengdu, Not set

Chongqing University Cancer Hospital, Chongqing, Not set

Deyang People's Hospital, Deyang, Not set

Fujian Cancer Hospital, Fuzhou, Not set

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Not set

Guangzhou First People's Hospital, Guangzhou, Not set

Nanfang Hospital, Southern Medical University, Guangzhou, Not set

Zhejiang Cancer Hospital, Hangzhou, Not set

Anhui Chest Hospital, Hefei, Not set

The Second Affiliated Hospital of Nanchang University, Jiangxi, Not set

Shandong Cancer Hospital, Jinan, Not set

Jiangxi Chest Hospital, Nanchang, Not set

Nanjing Drum Tower Hospital, Nanjing, Not set

Guangxi Medical University Cancer Hospital, Nanning, Not set

Shanghai Chest Hospital, Shanghai, Not set

Shanghai Pulmonary Hospital, Shanghai, Not set

Cancer Hospital of Shantou University Medical College, Shantou, Not set

Tianjin Medical University Cancer Institute & Hospital, Tianjin, Not set

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Not set

Tongji Hospital Tongji Medical College of Hust, Wuhan, Not set

The First Affiliated Hospital of Xian Jiaotong University, Xi'an, Not set

The First Affiliated Hospital of Xinxiang Medical College, Xinxiang, Not set

Henan Cancer Hospital, Zhengzhou, Not set

Ambroise-Pare Hospital, Assistance Publique - Hopitaux de Paris, Boulogne-Billancourt, Not set

CHU de Caen, Caen, Not set

Clinique Victor Hugo, Centre de Cancerologie de la Sarthe, Le Mans, Not set

Hopital Nord, Marseille, Not set

Institut de Cancer de Montpellier (ICM) - Val d'Aurelle, Montpellier, Not set

Centre Antoine Lacassagne, Nice, Not set

Institut de cancerologie de l'ouest (ICO), Saint-Herblain, Not set

Hopital d'Instruction des Armees (HIA) Begin, Saint-Mandé, Not set

Centre Hospitalier de Saint-Quentin, Saint-Quentin, Not set

Institut de Cancerologie Strasbourg Europe (ICANS), Strasbourg, Not set

Hôpital Foch, Suresnes, Not set

CHI de Toulon la Seyne-sur-Mer Hopital Sainte Musse, Toulon cedex, Not set

Augusta-Kranken-Anstalt gGmbh Klinik für Hämatologie Onkologie und Palliativmedizin, Bochum, Not set

Klinikum Chemnitz gGmbH, Chemnitz, Not set

Universitatsklinikum Essen / Westdeutsches Tumorzentrum, Innere Klinik (Tumorforschung), Essen, Not set

Universitätsklinikum Freiburg, Klinik für Innere Medizin I Hämatologie, Onkologie und Stammzelltransplantation, Freiburg, Not set

LungenClinic Grosshansdorf, Grosshansdorf, Not set

Krankenhaus Martha-Maria Halle Dölau, Halle, Not set

Asklepios Kliniken Hamburg, Hamburg, Not set

Katholisches Marienkrankenhaus gGmbH, Hamburg, Not set

Lungenklinik Hemer, Zentrum fur Pneumologie and Thoraxchirurgie, Hemer, Not set

Vincentius-Diakonissen-Kliniken gAG, St. Vincentius-Kliniken, Medizinische Klinik 2, Karlsruhe, Not set

Klinikum Kassel, Kassel, Not set

Kliniken der Stadt Köln ggmbh, Krankenhaus Koln-Merheim/Lungenklinik, Köln, Not set

Universitatsklinikum Schleswig-Holstein, Lubeck, Not set

Johannes Wesling Klinikum Minden, Minden, Not set

Munchen Klinik Bogenhausen, Klinik fur Pneumologie und Pneumologische Onkologie, Munchen, Not set

Sana Klinikum Offenbach GmbH, Medizinische Klinik IV, Hämatologie und Internistische Onkologie, Offenbach, Not set

Queen Elizabeth Hospital, Hong Kong, Not set

Queen Mary Hospital, Hong Kong, Not set

Prince of Wales Hospital, New Territories, Not set

Soroka University Medical Center, Itzchak Rager Blvd., Beer Seva, Not set

Shaare Zedek Medical Center, Jerusalem, Not set

Oncology Institute, Galilee Medical Center, Route 89 Nahariya-Cabri, Nahariya, Not set

Rabin Medical Center, Petah Tiqva, Not set

Kaplan Medical Center, Rehovot, Not set

Tel-Aviv Sourasky Medical Center, Tel Aviv, Not set

Azienda Ospedaliera San Giuseppe Moscati, Avellino, Not set

IRCCS Fondazoine del Piemonte per l'Oncologia, Candiolo, Not set

Azienda Socio Sanitaria Territoriale di Cremona, Cremona, Not set

Ospedale Policlinico San Martino, Genova, Not set

Ospedale San Raffaele, Milano, Not set

Azienda Ospedaliero Universitaria di Modena, Modena, Not set

AORN Cardarelli, Naples, Not set

Azienda Ospedaliera dei Colli, Napoli, Not set

IRCCS Policlinico S. Matteo, Dipartimento Oncologia Ematologia-Oncologia Medica, Pavia, Not set

Azienda Sanitaria Territoriale Pesaro e Urbino (AST), Pesaro, Not set

Ospedale Guglielmo da Saliceto AUSL di Piacenza, Piacenza, Not set

Centro di Riferimento Oncologico, Pordenone, Not set

Regina Elena Institute for Cancer Research, Rome, Not set

ASST Bergamo Ovest- ospedale di Treviglio, Treviglio, Not set

National Cancer Center Hospital East, Chiba, Not set

National Hospital Organization Shikoku Cancer Center, Ehime, Not set

Kyushu University Hospital, Fukuoka, Not set

Kurume University Hospital, Fukuoka, Not set

National Hospital Organization Himeji Medical Center, Hyogo, Not set

Hyogo Cancer Center, Hyogo, Not set

Kanazawa University Hospital, Ishikawa, Not set

Kanagawa Cancer Center, Kanagawa, Not set

Sendai Kousei Hospital, Miyagi, Not set

Niigata Cancer Center Hospital, Niigata, Not set

Osaka Metropolitan University Hospital, Osaka, Not set

Osaka Medical and Pharmaceutical University Hospital, Osaka, Not set

Kindai University Hospital, Osaka, Not set

National Hospital Organization Kinki Chuo Chest Medical Center, Osaka, Not set

Saitama Medical University, Saitama, Not set

SMG - SNU Boramae Medical Center, Dongjak-Gu, Not set

Samsung Medical Center, Gangnam-Gu, Not set

National Cancer Center, Goyang, Not set

Chungbuk National University Hospital, Heungdeok-Gu, Not set

Inha University Hospital, Incheon, Not set

Gachon University Gil Medical Center, Inchon, Not set

Kosin University Gospel Hospital, Seo-gu, Not set

Severance Hospital, Yonsei University Health System, Seoul, Not set

Asan Medical Center, Seoul, Not set

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Not set

Ajou University Hospital, Suwon-si, Not set

The Catholic University of Korea, Saint Vincent's Hospital, Suwon, Not set

Health Pharma Professional Research S.A. de C.V., Mexico, Not set

Hospital Universitario Dr. Jose Eleuterio Gonzalez, Mitras Centro, Not set

Oaxaca Site Management Organization, Oaxaca, Not set

Centro de Investigacion Clinica de Oaxaca, Oaxaca, Not set

Clinical Medical Research SC., Orizaba Centro, Not set

Clinica Integral Internacional de Oncologia S de RL de CV, Puebla, Not set

FAICIC Clínical Research, Veracruz, Not set

Amphia Ziekenhuis, Breda, Not set

Ziekenhuis Gelderse Vallei, Ede, Not set

Universitair Medisch Centrum Groningen, Groningen, Not set

Ziekenhuis St Jansdal, Harderwijk, Not set

TweeSteden Ziekenhuis, Tilburg, Not set

Hospital Prof. Doutor Fernando Fonseca, Amadora, Not set

Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Not set

Fundacao Champalimaud, Lisboa, Not set

Centro Hospitalar Universitário Lisboa Norte - Hospital Pulido Valente, Lisboa, Not set

Hospital Beatriz Angelo. Hospital de Loures., Lisbon, Not set

Centro Hospitalar Universitario Sao Joao, EPE, Porto, Not set

Unidade Local de Saude de Matosinhos EPE - Hospital Pedro Hispano SA, Senhora da Hora, Not set

Raffles Hospital, Singapore, Not set

Tang Tock Seng Hospital, Singapore, Not set

Hospital Clinic de Barcelona, Barcelona, Not set

Hospital de la Santa Creu i de Sant Pau, Barcelona, Not set

Hospital Universitari Dexeus (USP Institut Universitari Dexeus/Hospital Universitari Quiron Dexeus), Barcelona, Not set

Hospital Universitari Vall D'Hebron, Barcelona, Not set

Hospital Parc Tauli, Barcelona, Not set

Hospital Universitario Reina Sofia, Cordoba, Not set

Hospital Doctor Josep Trueta, Girona, Not set

Hospital Universitario de Jaen, Jaen, Not set

Hospital Universitario de Canarias, Las Palmas de G.C., Not set

Hospital Universitario Fundacion Jimenez Diaz, Madrid, Not set

Clinica Universidad de Navarra, Madrid, Not set

Hospital Universitario La Paz, Madrid, Not set

Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda, Not set

Hospital Sant Joan de Reus, Reus, Not set

Hospital Regional Universitario de Malaga, Rincon de la Victoria, Not set

Hospital Universitario Virgen Macarena, Sevilla, Not set

Hospital Universitario Virgen del Rocio, Seville, Not set

Instituto Valenciano De Oncologia (IVO), Valencia, Not set

Hospital Universitari i Politecnic La Fe, Valencia, Not set

Hospital Vithas Valencia 9 de Octubre, Valencia, Not set

Changhua Christian Hospital, Changhua City, Not set

E-DA Hospital, Kaohsiung City, Not set

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Not set

Chang Gung Memorial Hospital Kaohsiung, Kaohsiung, Not set

National Cheng Kung University Hospital, Tainan, Not set

Chi Mei Hospital, Liouying, Tainan, Not set

National Taiwan University Hospital, Taipei City, Not set

Taipei Veterans General Hospital, Taipei, Not set

Chang Gung Memorial Hospital Linkou Branch of the Chang Gung Medical Foundation, Taoyuan City, Not set

Ankara Bilkent Sehir Hastanesi, Ankara, Not set

Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi, Ankara, Not set

Trakya University Faculty of Medicine, Edirne, Not set

Istanbul University Cerrahpasa Medical Faculty Hospital, Fatih, Not set

Goztepe Prof. Dr. Suleyman Yalcın Sehir Hastanesi, Istanbul, Not set

Medipol Mega University Hospital, Istanbul, Not set

Acibadem Mehmet Ali Aydinlar Universitesi Atakent Hastanesi, Kaakaekmece, Not set

Turgut Ozal Medical Faculty, Malatya, Not set

Colchester General Hospital, Colchester, Not set

St Bartholomew's Hospital, Barts Health NHS Trust, London, Not set

The Christie NHS Foundation Trust, Department of Medical Oncology, Manchester, Not set

University Hospital Southampton Nhs Foundation Trust, Southampton, Not set

Conditions: Non-small Cell Lung Cancer

Learn More ›

Pilot Prospective Study for PET-CT Imaging in Participants With Relapsed/Refractory Acute Leukemias

NCT05969002

Recruiting

Background Acute lymphoblastic leukemia (ALL) accounts for about 25 percent of childhood cancers and for about 20 percent of adult leukemias. The disease can be treated with CAR T-cell infusion but non-central nervous system (CNS) extramedullary disease (EMD) is associated with lower rates of complete remission. 18-fludeoxyglucose (18F-FDG) positron emission tomography-computed tomography (PET-CT) has been shown to be effective for detection of non-CNS EMD in ALL. Pre and post CAR T-cell infusi... Read More

Gender:

ALL

Ages:

Between 5 years and 39 years

Trial Updated:

05/16/2025

Locations: National Institutes of Health Clinical Center, Bethesda, Maryland

Conditions: B Cell, Acute Lymphoblastic Leukemia, Relapsed/Refractory

Learn More ›

Combined Exercise and Targeted Therapy for Post-Stroke Reading Deficits

NCT06213272

Recruiting

The goal of the proposed project is to test the effectiveness of a novel hybrid approach to treatment of reading disorders after stroke, in which exercise training will be used in combination with a targeted reading treatment. This approach is expected to increase cerebral circulation and help to rebuild and strengthen the damaged phonological neural networks. Through this combinatory approach, the study aims to enhance the reading and language improvements seen with existing treatments.

Gender:

ALL

Ages:

Between 18 years and 85 years

Trial Updated:

05/16/2025

Locations: Kessler Foundation, West Orange, New Jersey

Conditions: Stroke, Aphasia, Reading Disorder

Learn More ›

The Effects of External Nasal Dilator Strips on Sleep and Cardiovascular Health

NCT06403098

Recruiting

The goal of this interventional study is to learn if wearing an external nasal dilator strip while sleeping changes objective and perceived sleep quality, immediate post-waking blood pressure, and immediate-post waking heart rate variability.

Gender:

ALL

Ages:

Between 18 years and 30 years

Trial Updated:

05/16/2025

Locations: Cardiovascular and Applied Physiology Laboratory, Tallahassee, Florida

Conditions: Healthy

Learn More ›

IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers

NCT06616844

Recruiting

A multi-center, prospective, observer-blinded, randomized controlled clinical trial to evaluate the efficacy of PPECM augmented standard of care versus standard of care alone in the management of hard-to-heal diabetic foot ulcers.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

05/16/2025

Locations: Angel City Research, Los Angeles, California +8 locations

Conditions: Wound Heal, Ulcer

Learn More ›

A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity

NCT06859268

Recruiting

This is a study of retatrutide in participants with obesity. The main purpose is to learn more about how retatrutide maintains body weight loss. The study will have two treatment phases: an 80 week lead-in phase in which all participants will take retatrutide dose 1 and a 36 week randomized, double-blinded phase in which participants will either take retatrutide dose 1, retatrutide dose 2, or switch to placebo. Participation in the study will last around 125 weeks.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

05/16/2025

Locations: Southern California Clinical Research, Santa Ana, California +52 locations

Southern California Clinical Research, Santa Ana, California

University of Colorado Anschutz Medical Campus, Aurora, Colorado

CMR of Greater New Haven, LLC, Hamden, Connecticut

ALL Medical Research, LLC, Cooper City, Florida

Florida International Medical Research, Coral Gables, Florida

Renstar Medical Research, Ocala, Florida

Charter Research - Winter Park, Orlando, Florida

Metabolic Research Institute, Inc., West Palm Beach, Florida

Kubost Clinical Research - Marietta, Marietta, Georgia

North Georgia Clinical Research, Woodstock, Georgia

Pacific Diabetes & Endocrine Center, Honolulu, Hawaii

Alliance for Multispecialty Research, LLC, Oak Brook, Illinois

Springfield Clinic Main Campus, Springfield, Illinois

Alliance for Multispecialty Research, LLC, Lexington, Kentucky

L-MARC Research Center, Louisville, Kentucky

Pennington Biomedical Research Center, Baton Rouge, Louisiana

Care Access - Lake Charles (Bayou Pines), Lake Charles, Louisiana

Massachusetts General Hospital, Boston, Massachusetts

Alliance for Multispecialty Research, LLC, Kansas City, Missouri

Vector Clinical Trials, Las Vegas, Nevada

Dent Neurosciences Research Center, Inc, Amherst, New York

Carteret Medical Group, Morehead City, North Carolina

Care Access - Raleigh, Raleigh, North Carolina

Tekton Research, LLC., Moore, Oklahoma

Altoona Center For Clinical Research, Duncansville, Pennsylvania

Care Access - Rapid City, Rapid City, South Dakota

Alliance for Multispecialty Research, LLC, Knoxville, Tennessee

Care Access - Houston, Houston, Texas

Southern Endocrinology Associates, Mesquite, Texas

Sleep Therapy Research Center, San Antonio, Texas

National Clinical Research, Inc, Richmond, Virginia

Northwest Clinical Research Center, Bellevue, Washington

Central Washington Health Services Association d/b/a Confluence Health, Wenatchee, Washington

Aggarwal and Associates Limited, Brampton, Ontario

Circulate Cardiac & Vascular Centre, Burlington, Ontario

Med Trust Research, Courtice, Ontario

Winterberry Research Inc., Hamilton, Ontario

Care Access - Thunder Bay - Barton Street, Thunder Bay, Ontario

Maple Leaf Research, Toronto, Ontario

Centre de Medecine Metabolique de Lanaudiere (CMML), Terrebonne, Quebec

C.I.C. Mauricie inc., Trois-Rivières, Quebec

Atlantic Medical, Penzance, Cornwall

Rame Group Practice, Torpoint, Cornwall

St Bartholomew's Medical Centre, Oxford, England

Oakenhurst Medical Practice, Blackburn, Lancashire

Layton Medical Centre, Blackpool, Lancashire

HMC Health Group - Meadows Centre for Health, Hounslow, London, City Of

Cheadle Community Hospital, Cheadle, Staffordshire

Bradford on Avon Health Centre, Bradford on Avon, Wiltshire

FutureMeds - Liverpool, Bromborough, Wirral

FutureMeds - Birmingham, Birmingham, Not set

The Adam Practice, Poole, Not set

Woodstock Bower Surgery, Rotherham, Not set

Conditions: Obesity

Learn More ›

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma

NCT00040352

Recruiting

This study will investigate how genetic and environmental factors contribute to the development of melanoma, a type of skin cancer, and related conditions. Individuals \>=4 weeks with a personal or family history of melanoma or atypical spitzoid/Spitz tumor may be eligible for this study. Participants will: * Fill out one or two questionnaires about their personal and family medical history. * Provide written consent for researchers to review their medical records and pathology materials related to their care and those of deceased relatives with melanomas, tumors, cancer, or other related illnesses for whom they are the next-of-kin or legally authorized representative. * Donate a blood or cheek cell sample to be used for genetic studies. (The blood sample is collected through a needle in an arm vein. The cheek cell sample is obtained either by gently brushing the inside of the mouth with a soft brush or by swishing a tablespoon of mouthwash and then spitting it into a container.) * Undergo a skin biopsy (removal of a small piece of skin tissue) for genetic study. For this procedure, the area of skin to be removed is numbed with a local anesthetic and a 1/4-inch piece of skin is excised with a cookie cutter-like instrument. The wound is then covered with a band-aid. Participants may be asked to travel to the NIH Clinical Center for evaluation, including a medical history, physical examination, and some of the following procedures: * Full body skin examination to evaluate the type and number of moles and document any evidence of sun damage to the skin. The examination involves all the skin from the scalp to the bottoms of the feet. After the examination, a medical photographer will photograph the skin, with close-ups of skin lesions marked by the examiner. If there are parts of the skin the participant does not want examined or photographed, he or she can tell the examiner. * Blood draw of about 120 milliliters (4 ounces) or less * Skin biopsy * Cheek cell sample * X-rays, ultrasound and magnetic resonance imaging (MRI) studies to detect tumors or changes in tumors or other types of changes in specific tissues. MRI is a diagnostic test that uses strong magnetic fields and radiowaves to examine body tissues. The subject lies on a table that is moved into a large tunnel-like machine (the scanner) for about 45 minutes to 1 hour. When the tests are finished, a doctor will discuss the results with the participant and the need, if any, for clinical follow-up.... Read Less

Gender:

ALL

Ages:

Between 4 weeks and 99 years

Trial Updated:

05/16/2025

Locations: National Cancer Institute (NCI), Bethesda, Maryland +1 locations

Conditions: Melanoma, Dysplastic Nevus Syndrome

Learn More ›